USA: The VA Will Eliminate Hepatitis C In Veterans By Year-End

At the 24th Annual Wharton Health Care Business Conference, Dr. David J. Shulkin, the Secretary of the U.S. Department of Veterans Affairs, announced that the VA was on track to eliminate hepatits C infections in the next 12 months for those who are willing and able to be treated. In October 2014, the VA had over 146,000 veterans afflicted with hepatitis C. By next October, this number will be only 20,000. How did this happen? Here’s the VA’s response as

U.S.: VA estimates 107,000 vets have undiagnosed or untreated hepatitis C

WASHINGTON — With more than $2 billion appropriated for new hepatitis C drugs during the past two years, the Department of Veterans Affairs treated 65,000 veterans for the virus, but about 87,000 remain untreated and an additional 20,000 are undiagnosed. VA officials are seeking $1.5 billion in the 2017 fiscal year to treat more veterans, a group in which hepatitis C is especially prevalent. Funding for the latest drugs, which have a high cure rate, is n

U.S.: VA expands hepatitis C treatment to all patients with the virus

The Veterans Affairs Department will begin providing hepatitis C treatment to all veterans in its health system who have the virus, regardless of their disease stage, VA officials said Wednesday.Having received a boost in funding from Congress late last year for the costly medications needed to cure hepatitis C, the VA is now able to treat the 174,000 veterans in its health system who have the disease, according to a VA release.VA Under Secretary for Healt

U.S.: Lawmaker: Costly hepatitis C drug “a slap in the face to the veterans”

A Congressional hearing will begin Wednesday in response to a CBS News investigation that showed how a costly new cure for hepatitis C isn't making it to most of the 200,000 U.S. veterans infected with the disease, many as a result of their service. Congress has given $2.7 billion taxpayer to treat veterans with hepatitis C, but only 15 percent have been treated with the drug, one that might not exist without government funding.The drug at the center of We